)
B&G Foods (BGS) investor relations material
B&G Foods Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 net sales rose 4.7% to $459.8M; base-business sales grew 5.0% to $404.6M, led by 6.1% volume growth. 9M base-business sales increased 1.8%, while total sales fell 2.9% to $1.252B.
Q3 adjusted EBITDA rose 16.2% to $81.8M; 9M adjusted EBITDA increased 6.6% to $199.9M. GAAP net losses widened to $32.5M in Q3 and $69.0M in 9M.
Financial highlights
Q3 gross profit was $108.9M, or 23.7% of sales; adjusted gross profit was $111.2M, or 24.2%, versus 22.5% a year earlier.
Q3 adjusted net income was $17.8M, or $0.21 per adjusted diluted share, versus $11.7M and $0.15; 9M adjusted net income was $29.5M, or $0.36, versus $18.1M and $0.23.
Q3 operating income rose to $14.2M from $11.0M; net loss widened to $32.5M from $19.1M, including a $40.7M non-cash intangible impairment.
9M operating income fell to $37.9M from $68.9M, while adjusted EBITDA rose to $199.9M from $187.5M.
Q3 net interest expense rose 20.1% to $44.8M; 9M expense rose 7.4% to $119.1M, reflecting higher average debt and 11.00% notes.
Outlook and guidance
FY2026 net sales guidance increased to $1.760B–$1.800B and adjusted EBITDA to $280M–$290M; adjusted diluted EPS guidance was reaffirmed at $0.575–$0.675.
Guidance reflects one fewer reporting week and specified acquisitions, divestitures and co-manufacturing arrangements; it excludes a potential Green Giant Canada divestiture.
FY2026 capex is expected at $25M or less; $19M was incurred in 9M, of which $17.8M was paid in cash.
Priorities include improving productivity, cost savings and cash generation while reducing leverage.
- Execution, portfolio focus, and operational improvements drive growth and deleveraging.BGS
Barclays 19th Annual Global Consumer Conference - Q2 2026 sales dropped 9.7% but margins and EBITDA improved, with guidance reaffirmed.BGS
Q2 2026 - Portfolio reshaping led to higher base sales, a net loss, and a 50% dividend cut.BGS
Q1 2026 - Votes will be cast on directors, executive pay, and auditor ratification at the 2026 virtual meeting.BGS
Proxy filing - Annual meeting to vote on directors, executive pay, auditor, and highlight ESG and governance.BGS
Proxy filing - Divestitures and margin gains shape 2025 results, with cautious guidance for 2026.BGS
Q4 2025 - Q3 2024 net sales fell 8.3% to $461.1M, with lower guidance and ongoing margin pressures.BGS
Q3 2024 - Q1 2025 net sales fell 10.5% and guidance was lowered as cost cuts and portfolio changes accelerate.BGS
Q1 2025 - Sequential improvement, major impairments, and cautious 2025 outlook with portfolio reshaping.BGS
Q4 2024
)
)
)
)
)
)
)
)